Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Heparin therapy in brain-dead organ donors
IRCT20130304012695N16Phase 2Completed
- Sponsor
- Tehran University of Medical Sciences
- Start
- Apr 2021
- Modality
- Small Molecules, Recombinant Proteins and Enzymes
- Countries
- 1
01
Overview
Phase 2, randomised, double-blind trial of heparin in brain death and Hypercoagulability (2 arms), sponsored by Tehran University of Medical Sciences. Primary endpoints: Kidney graft function in recipients and Liver graft function in recipients. Started Apr 2021; status: completed.
02
Drugs
heparin
03
Conditions
brain deathHypercoagulability
Beyond the preview
Go deeper on IRCT20130304012695N16.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on IRCT20130304012695N16.